Antagonistic controls regulate copy number of the yeast 2 mu plasmid.
J. A. H. Murray(Cardiff University), Gianni Cesareni(University of Rome Tor Vergata), Maurizio Scarpa(University of Udine), Nilce Maria Martinez Rossi(European Molecular Biology Organization)
Cited by 110
Related Papers
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|522
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
|The Journal of Pediatrics|2006|364
Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier
|Journal of Cerebral Blood Flow & Metabolism|2012|307
Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
|Journal of Inherited Metabolic Disease|2011|302
Possible strategies to cross the blood–brain barrier
|The Italian Journal of Pediatrics/Italian journal of pediatrics|2018|255